[1]张静,高晓杰,富颖超,等.董氏奇穴联合丁沉扶正汤改善胃癌术后患者肠道菌群紊乱的作用机制研究[J].西部中医药,2023,36(12):1-6.[doi:10.12174/j.issn.2096-9600.2023.12.01]
　ZHANG Jing,GAO Xiaojie,FU Yingchao,et al.Research on the Mechanism of Dong′s Unique Acupoints and Dingchen Fuzheng Tang in the Improvement of Postoperative Intestinal Flora Disorder in Patients with Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(12):1-6.[doi:10.12174/j.issn.2096-9600.2023.12.01]
点击复制

董氏奇穴联合丁沉扶正汤改善胃癌术后患者肠道菌群紊乱的作用机制研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年12期
页码:
1-6
栏目:
理论论著
出版日期:
2023-12-15

文章信息/Info

Title:
Research on the Mechanism of Dong′s Unique Acupoints and Dingchen Fuzheng Tang in the Improvement of Postoperative Intestinal Flora Disorder in Patients with Gastric Cancer
作者:
张静1, 高晓杰1, 富颖超1, 韩玫1, 邓力威1, 陈娟2
1.河北省退役军人总医院，河北 邢台 054000
2.邢台市中医院，河北 邢台 054001
Author(s):
ZHANG Jing1, GAO Xiaojie1, FU Yingchao1, HAN Mei1, DENG Liwei1, CHEN Juan2
1.Hebei General Hospital for Veterans, Xingtai 054000, China
2.Xingtai Hospital of TCM, Xingtai 054001, China
关键词:
胃癌; 董氏奇穴; 丁沉扶正汤; 肠道菌群; 环芳香烃受体/白细胞介素22/信号转导和转录激活因子3通路; 作用机制
Keywords:
gastric cancer; unique acupoints; intestinal flora; AhR/IL-22/STAT3 pathway; mechanism of action
分类号:
R735.2
DOI:
10.12174/j.issn.2096-9600.2023.12.01
文献标志码:
A
摘要:
目的通过环芳香烃受体（cyclic aromatic hydrocarbon receptor，AhR）/白细胞介素22（interleukin-22，IL-22）/信号转导和转录激活因子3（signal transducer and activator of transcription 3，STAT3）通路探讨董氏奇穴联合丁沉扶正汤对胃癌患者术后肠道菌群紊乱的影响，并探讨其具体作用机制。 方法选择接受腹腔镜下胃癌根治术的患者120例，随机分为对照组和针药联合组，每组60例。对照组接受董氏奇穴针灸治疗，针药联合组在对照组的基础上给予丁沉扶正汤治疗。比较两组术中指标、T淋巴细胞亚群、D-乳酸（D-Lactic acid，D-LA）、炎性因子、肠道细菌以及肠黏膜组织AhR/IL-22/STAT3通路转录和翻译水平。 结果两组干预前指标比较，差异无统计学意义（P＞0.05）。干预后两组乳酸杆菌、双歧杆菌含量、CD3+、CD4+、CD4+/CD8+比值均升高（P＜0.05），且上述指标针药联合组均高于对照组（P＜0.05）。干预后两组肠道中大肠杆菌、梭菌、拟杆菌、柔嫩梭菌水平及血清中D-乳酸、降钙素原、C反应蛋白（C-reactive protein，CRP）和白细胞介素-6（interleukin-6，IL-6）水平均降低（P＜0.05），且以上指标针药联合组均显著低于对照组（P＜0.05）。针药联合组住院时间显著短于对照组（P＜0.05）。与干预前比较，两组AhR、IL-22和STAT3 mRNA及蛋白水平均升高（P＜0.05），针药联合组高于对照组（P＜0.05）。 结论董氏奇穴联合丁沉扶正汤可能通过促进AhR/IL-22/STAT3通路保护肠黏膜屏障，进而改善胃癌患者术后的细胞免疫功能、缓解肠道菌群失衡，促进患者恢复。
Abstract:
ObjectiveTo explore the effects of Dong's unique acupoints combined with Dingchen Fuzheng Tang on postoperative intestinal flora disorder in patients with gastric cancer through the cyclic aromatic hydro-carbon receptor (AhR)/interleukin-22 (interleukin, IL-22)/STAT3 pathway, and discuss its specific mechanism of action. MethodsAll 120 patients who accepted laparoscopic radical resection of gastric cancer were chosen, and randomized into the control group and the needle-medicine combination group, with 60 cases in each group. The control group accepted the acupuncture treatment of Dong's unique acupoints, and the needle-medicine combina-tion group was treated with Dingchen Fuzheng Tang based on acupuncture. To compare intraoperative indicators, T lymphocyte subsets, D-LA, inflammatory factors, intestinal bacteria and transcription and translation levels of AhR/IL-22/STAT3 pathway in intestinal mucosa tissue between both groups. ResultsThe difference had no statistical meaning in the indicators between both groups before the intervention (P<0.05). After the intervention, the contents of lactic acid bacillus and bacillus bifidus, CD3+, CD4+, CD4+/CD8+ ratio were increased in the two groups (P<0.05), and the above indicators in the needle-medicine combination group were significantly higher than these of the control group (P<0.05). After the intervention, the levels of Escherichia coli, clostridium, bacteroides and C. tenens in the intestine, the levels of serum D-LA, calcitonin, CRP and IL-6 were decreased in two groups (P<0.05), and the above indicators of the needle-medicine combination group were remarkably lower than these of the control group (P<0.05). The needle-medicine combination group was noticeably lower than the control group in length of stay (P<0.05). Compared with before the intervention, the levels of AhR, IL-22 and STAT3 mRNA and protein were raised in both groups (P<0.05), the needle-medicine combination group was clearly higher than the control group (P<0.05). ConclusionDong's unique acupoints combined with Dingchen Fuzheng Tang could protect intestinal mucosa barrier possibly through promoting AhR/IL-22/STAT3 pathway, thereby improving the patients' postoperative cellular immunity, relieving intestinal flora disorder and promoting the patients' recovery.

相似文献/References:

[1]熊墨年,唐晓玲,余炅,等.益气清毒法联合化疗治疗中晚期胃癌的临床观察[J].西部中医药,2011,24(11):35.
[2]张小仙,倪角角,陈辉.舒适护理在晚期胃癌患者中的应用[J].西部中医药,2012,25(12):105.
　ZHANG Xiao-xian,NI Jiao-jiao,CHEN Hui.Application of Comfort Care to the Patients with Gastric Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(12):105.
[3]王宏伟,程小丽,许雅清,等.苦马豆素对胃癌细胞中pten和survivin mRNA表达的影响[J].西部中医药,2015,28(12):25.
[4]胡玥,刘沈林.刘沈林教授“胃肾同治”理论探讨及其在胃癌中的应用[J].西部中医药,2015,28(10):72.
[5]朱剑梅,李世军.莲芪胶囊配合化疗治疗胃癌的临床研究[J].西部中医药,2015,28(12):91.
[6]李雅娟.围手术期护理对胃癌根除术患者护理质量的影响[J].西部中医药,2012,25(12):113.
　LI Ya-juan.Influence of Perioperative Care on Nursing Quality of Patients Undergoing Radical Resection of Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(12):113.
[7]刘河,刘超,杨世勇.胃癌中医证型与病灶组织中MMP-9、TIMP-2和HER-2表达的相关性分析[J].西部中医药,2017,30(02):134.
　LIU He,LIU Chao,YANG Shiyong.Correlation Analysis btween TCM Syndrome of Gastric Cancer and the Expression of MMP-9, TIMP-2 and HER-2 in Focus Tissue[J].Western Journal of Traditional Chinese Medicine,2017,30(12):134.
[8]王志新,邹玺,胡守友.中药抗胃癌的现代药理机制[J].西部中医药,2016,29(04):137.
　WANG Zhixin,ZOU Xi,HU Shouyou.Modern Pharmacological Mechanism of Herbs Fighting against Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2016,29(12):137.
[9]白兆琴,王惠霞,王宏伟△.黄芩苷对胃癌SGC-7901细胞TLR8、HIF-1α、PDGFβ和pten表达的影响[J].西部中医药,2017,30(08):12.
　BAI Zhaoqin,WANG Huixia,WANG Hongwei.The Effects of Baicalin on the Expression of TLR8, HIF-1α, PDGFβ and pten of Gastric Cancer SGC-7901 Cells[J].Western Journal of Traditional Chinese Medicine,2017,30(12):12.
[10]王亚峰,谢亲建,丁晓煜,等.白刺对胃癌MGC-803细胞的抑制作用[J].西部中医药,2018,31(05):14.
　WANG Yafeng,XIE Qinjian,DING Xiaoyu,et al.Study of Inhibitory Action of BaiCi on Gastric Cancer MGC-803 Cells[J].Western Journal of Traditional Chinese Medicine,2018,31(12):14.

备注/Memo

备注/Memo:
张静（1987—），女，硕士学位，主治医师。研究方向：慢性病的中医药防治。河北省中医药管理局中医药计划项目（2021455）。
更新日期/Last Update: 2023-12-15